1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Pomalidomide API Annual Sales 2017-2028 2.1.2 World Current & Future Analysis for Pomalidomide API by Geographic Region, 2017, 2022 & 2028 2.1.3 World Current & Future Analysis for Pomalidomide API by Country/Region, 2017, 2022 & 2028 2.2 Pomalidomide API Segment by Purity 2.2.1 Above 98 % 2.2.2 Above 99 % 2.3 Pomalidomide API Sales by Purity 2.3.1 Global Pomalidomide API Sales Market Share by Purity (2017-2022) 2.3.2 Global Pomalidomide API Revenue and Market Share by Purity (2017-2022) 2.3.3 Global Pomalidomide API Sale Price by Purity (2017-2022) 2.4 Pomalidomide API Segment by Application 2.4.1 Capsules 2.4.2 Others 2.5 Pomalidomide API Sales by Application 2.5.1 Global Pomalidomide API Sale Market Share by Application (2017-2022) 2.5.2 Global Pomalidomide API Revenue and Market Share by Application (2017-2022) 2.5.3 Global Pomalidomide API Sale Price by Application (2017-2022) 3 Global Pomalidomide API by Company 3.1 Global Pomalidomide API Breakdown Data by Company 3.1.1 Global Pomalidomide API Annual Sales by Company (2020-2022) 3.1.2 Global Pomalidomide API Sales Market Share by Company (2020-2022) 3.2 Global Pomalidomide API Annual Revenue by Company (2020-2022) 3.2.1 Global Pomalidomide API Revenue by Company (2020-2022) 3.2.2 Global Pomalidomide API Revenue Market Share by Company (2020-2022) 3.3 Global Pomalidomide API Sale Price by Company 3.4 Key Manufacturers Pomalidomide API Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Pomalidomide API Product Location Distribution 3.4.2 Players Pomalidomide API Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Pomalidomide API by Geographic Region 4.1 World Historic Pomalidomide API Market Size by Geographic Region (2017-2022) 4.1.1 Global Pomalidomide API Annual Sales by Geographic Region (2017-2022) 4.1.2 Global Pomalidomide API Annual Revenue by Geographic Region 4.2 World Historic Pomalidomide API Market Size by Country/Region (2017-2022) 4.2.1 Global Pomalidomide API Annual Sales by Country/Region (2017-2022) 4.2.2 Global Pomalidomide API Annual Revenue by Country/Region 4.3 Americas Pomalidomide API Sales Growth 4.4 APAC Pomalidomide API Sales Growth 4.5 Europe Pomalidomide API Sales Growth 4.6 Middle East & Africa Pomalidomide API Sales Growth 5 Americas 5.1 Americas Pomalidomide API Sales by Country 5.1.1 Americas Pomalidomide API Sales by Country (2017-2022) 5.1.2 Americas Pomalidomide API Revenue by Country (2017-2022) 5.2 Americas Pomalidomide API Sales by Purity 5.3 Americas Pomalidomide API Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Pomalidomide API Sales by Region 6.1.1 APAC Pomalidomide API Sales by Region (2017-2022) 6.1.2 APAC Pomalidomide API Revenue by Region (2017-2022) 6.2 APAC Pomalidomide API Sales by Purity 6.3 APAC Pomalidomide API Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Pomalidomide API by Country 7.1.1 Europe Pomalidomide API Sales by Country (2017-2022) 7.1.2 Europe Pomalidomide API Revenue by Country (2017-2022) 7.2 Europe Pomalidomide API Sales by Purity 7.3 Europe Pomalidomide API Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Pomalidomide API by Country 8.1.1 Middle East & Africa Pomalidomide API Sales by Country (2017-2022) 8.1.2 Middle East & Africa Pomalidomide API Revenue by Country (2017-2022) 8.2 Middle East & Africa Pomalidomide API Sales by Purity 8.3 Middle East & Africa Pomalidomide API Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Pomalidomide API 10.3 Manufacturing Process Analysis of Pomalidomide API 10.4 Industry Chain Structure of Pomalidomide API 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Pomalidomide API Distributors 11.3 Pomalidomide API Customer 12 World Forecast Review for Pomalidomide API by Geographic Region 12.1 Global Pomalidomide API Market Size Forecast by Region 12.1.1 Global Pomalidomide API Forecast by Region (2023-2028) 12.1.2 Global Pomalidomide API Annual Revenue Forecast by Region (2023-2028) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Pomalidomide API Forecast by Purity 12.7 Global Pomalidomide API Forecast by Application 13 Key Players Analysis 13.1 Mylan 13.1.1 Mylan Company Information 13.1.2 Mylan Pomalidomide API Product Offered 13.1.3 Mylan Pomalidomide API Sales, Revenue, Price and Gross Margin (2020-2022) 13.1.4 Mylan Main Business Overview 13.1.5 Mylan Latest Developments 13.2 Dr. Reddy's Laboratories 13.2.1 Dr. Reddy's Laboratories Company Information 13.2.2 Dr. Reddy's Laboratories Pomalidomide API Product Offered 13.2.3 Dr. Reddy's Laboratories Pomalidomide API Sales, Revenue, Price and Gross Margin (2020-2022) 13.2.4 Dr. Reddy's Laboratories Main Business Overview 13.2.5 Dr. Reddy's Laboratories Latest Developments 13.3 Hetero Drugs 13.3.1 Hetero Drugs Company Information 13.3.2 Hetero Drugs Pomalidomide API Product Offered 13.3.3 Hetero Drugs Pomalidomide API Sales, Revenue, Price and Gross Margin (2020-2022) 13.3.4 Hetero Drugs Main Business Overview 13.3.5 Hetero Drugs Latest Developments 13.4 Mac-Chem Products (India) Pvt.Ltd 13.4.1 Mac-Chem Products (India) Pvt.Ltd Company Information 13.4.2 Mac-Chem Products (India) Pvt.Ltd Pomalidomide API Product Offered 13.4.3 Mac-Chem Products (India) Pvt.Ltd Pomalidomide API Sales, Revenue, Price and Gross Margin (2020-2022) 13.4.4 Mac-Chem Products (India) Pvt.Ltd Main Business Overview 13.4.5 Mac-Chem Products (India) Pvt.Ltd Latest Developments 13.5 Shilpa Medicare 13.5.1 Shilpa Medicare Company Information 13.5.2 Shilpa Medicare Pomalidomide API Product Offered 13.5.3 Shilpa Medicare Pomalidomide API Sales, Revenue, Price and Gross Margin (2020-2022) 13.5.4 Shilpa Medicare Main Business Overview 13.5.5 Shilpa Medicare Latest Developments 13.6 Veranova 13.6.1 Veranova Company Information 13.6.2 Veranova Pomalidomide API Product Offered 13.6.3 Veranova Pomalidomide API Sales, Revenue, Price and Gross Margin (2020-2022) 13.6.4 Veranova Main Business Overview 13.6.5 Veranova Latest Developments 13.7 Natco Pharma Limited 13.7.1 Natco Pharma Limited Company Information 13.7.2 Natco Pharma Limited Pomalidomide API Product Offered 13.7.3 Natco Pharma Limited Pomalidomide API Sales, Revenue, Price and Gross Margin (2020-2022) 13.7.4 Natco Pharma Limited Main Business Overview 13.7.5 Natco Pharma Limited Latest Developments 13.8 Mehta API 13.8.1 Mehta API Company Information 13.8.2 Mehta API Pomalidomide API Product Offered 13.8.3 Mehta API Pomalidomide API Sales, Revenue, Price and Gross Margin (2020-2022) 13.8.4 Mehta API Main Business Overview 13.8.5 Mehta API Latest Developments 13.9 Symed Labs Limited 13.9.1 Symed Labs Limited Company Information 13.9.2 Symed Labs Limited Pomalidomide API Product Offered 13.9.3 Symed Labs Limited Pomalidomide API Sales, Revenue, Price and Gross Margin (2020-2022) 13.9.4 Symed Labs Limited Main Business Overview 13.9.5 Symed Labs Limited Latest Developments 13.10 Hangzhou Longshine Bio-Tech 13.10.1 Hangzhou Longshine Bio-Tech Company Information 13.10.2 Hangzhou Longshine Bio-Tech Pomalidomide API Product Offered 13.10.3 Hangzhou Longshine Bio-Tech Pomalidomide API Sales, Revenue, Price and Gross Margin (2020-2022) 13.10.4 Hangzhou Longshine Bio-Tech Main Business Overview 13.10.5 Hangzhou Longshine Bio-Tech Latest Developments 13.11 Guangzhou Tosun Pharmaceutical 13.11.1 Guangzhou Tosun Pharmaceutical Company Information 13.11.2 Guangzhou Tosun Pharmaceutical Pomalidomide API Product Offered 13.11.3 Guangzhou Tosun Pharmaceutical Pomalidomide API Sales, Revenue, Price and Gross Margin (2020-2022) 13.11.4 Guangzhou Tosun Pharmaceutical Main Business Overview 13.11.5 Guangzhou Tosun Pharmaceutical Latest Developments 13.12 Sumar Biotech 13.12.1 Sumar Biotech Company Information 13.12.2 Sumar Biotech Pomalidomide API Product Offered 13.12.3 Sumar Biotech Pomalidomide API Sales, Revenue, Price and Gross Margin (2020-2022) 13.12.4 Sumar Biotech Main Business Overview 13.12.5 Sumar Biotech Latest Developments 13.13 Deva Holding AS 13.13.1 Deva Holding AS Company Information 13.13.2 Deva Holding AS Pomalidomide API Product Offered 13.13.3 Deva Holding AS Pomalidomide API Sales, Revenue, Price and Gross Margin (2020-2022) 13.13.4 Deva Holding AS Main Business Overview 13.13.5 Deva Holding AS Latest Developments 14 Research Findings and Conclusion

List of Tables Table 1. Pomalidomide API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions) Table 2. Pomalidomide API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions) Table 3. Major Players of Above 98 % Table 4. Major Players of Above 99 % Table 5. Global Pomalidomide API Sales by Purity (2017-2022) & (Kg) Table 6. Global Pomalidomide API Sales Market Share by Purity (2017-2022) Table 7. Global Pomalidomide API Revenue by Purity (2017-2022) & ($ million) Table 8. Global Pomalidomide API Revenue Market Share by Purity (2017-2022) Table 9. Global Pomalidomide API Sale Price by Purity (2017-2022) & (US$/Kg) Table 10. Global Pomalidomide API Sales by Application (2017-2022) & (Kg) Table 11. Global Pomalidomide API Sales Market Share by Application (2017-2022) Table 12. Global Pomalidomide API Revenue by Application (2017-2022) Table 13. Global Pomalidomide API Revenue Market Share by Application (2017-2022) Table 14. Global Pomalidomide API Sale Price by Application (2017-2022) & (US$/Kg) Table 15. Global Pomalidomide API Sales by Company (2020-2022) & (Kg) Table 16. Global Pomalidomide API Sales Market Share by Company (2020-2022) Table 17. Global Pomalidomide API Revenue by Company (2020-2022) ($ Millions) Table 18. Global Pomalidomide API Revenue Market Share by Company (2020-2022) Table 19. Global Pomalidomide API Sale Price by Company (2020-2022) & (US$/Kg) Table 20. Key Manufacturers Pomalidomide API Producing Area Distribution and Sales Area Table 21. Players Pomalidomide API Products Offered Table 22. Pomalidomide API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global Pomalidomide API Sales by Geographic Region (2017-2022) & (Kg) Table 26. Global Pomalidomide API Sales Market Share Geographic Region (2017-2022) Table 27. Global Pomalidomide API Revenue by Geographic Region (2017-2022) & ($ millions) Table 28. Global Pomalidomide API Revenue Market Share by Geographic Region (2017-2022) Table 29. Global Pomalidomide API Sales by Country/Region (2017-2022) & (Kg) Table 30. Global Pomalidomide API Sales Market Share by Country/Region (2017-2022) Table 31. Global Pomalidomide API Revenue by Country/Region (2017-2022) & ($ millions) Table 32. Global Pomalidomide API Revenue Market Share by Country/Region (2017-2022) Table 33. Americas Pomalidomide API Sales by Country (2017-2022) & (Kg) Table 34. Americas Pomalidomide API Sales Market Share by Country (2017-2022) Table 35. Americas Pomalidomide API Revenue by Country (2017-2022) & ($ Millions) Table 36. Americas Pomalidomide API Revenue Market Share by Country (2017-2022) Table 37. Americas Pomalidomide API Sales by Type (2017-2022) & (Kg) Table 38. Americas Pomalidomide API Sales Market Share by Purity (2017-2022) Table 39. Americas Pomalidomide API Sales by Application (2017-2022) & (Kg) Table 40. Americas Pomalidomide API Sales Market Share by Application (2017-2022) Table 41. APAC Pomalidomide API Sales by Region (2017-2022) & (Kg) Table 42. APAC Pomalidomide API Sales Market Share by Region (2017-2022) Table 43. APAC Pomalidomide API Revenue by Region (2017-2022) & ($ Millions) Table 44. APAC Pomalidomide API Revenue Market Share by Region (2017-2022) Table 45. APAC Pomalidomide API Sales by Purity (2017-2022) & (Kg) Table 46. APAC Pomalidomide API Sales Market Share by Purity (2017-2022) Table 47. APAC Pomalidomide API Sales by Application (2017-2022) & (Kg) Table 48. APAC Pomalidomide API Sales Market Share by Application (2017-2022) Table 49. Europe Pomalidomide API Sales by Country (2017-2022) & (Kg) Table 50. Europe Pomalidomide API Sales Market Share by Country (2017-2022) Table 51. Europe Pomalidomide API Revenue by Country (2017-2022) & ($ Millions) Table 52. Europe Pomalidomide API Revenue Market Share by Country (2017-2022) Table 53. Europe Pomalidomide API Sales by Type (2017-2022) & (Kg) Table 54. Europe Pomalidomide API Sales Market Share by Purity (2017-2022) Table 55. Europe Pomalidomide API Sales by Application (2017-2022) & (Kg) Table 56. Europe Pomalidomide API Sales Market Share by Application (2017-2022) Table 57. Middle East & Africa Pomalidomide API Sales by Country (2017-2022) & (Kg) Table 58. Middle East & Africa Pomalidomide API Sales Market Share by Country (2017-2022) Table 59. Middle East & Africa Pomalidomide API Revenue by Country (2017-2022) & ($ Millions) Table 60. Middle East & Africa Pomalidomide API Revenue Market Share by Country (2017-2022) Table 61. Middle East & Africa Pomalidomide API Sales by Purity (2017-2022) & (Kg) Table 62. Middle East & Africa Pomalidomide API Sales Market Share by Purity (2017-2022) Table 63. Middle East & Africa Pomalidomide API Sales by Application (2017-2022) & (Kg) Table 64. Middle East & Africa Pomalidomide API Sales Market Share by Application (2017-2022) Table 65. Key Market Drivers & Growth Opportunities of Pomalidomide API Table 66. Key Market Challenges & Risks of Pomalidomide API Table 67. Key Industry Trends of Pomalidomide API Table 68. Pomalidomide API Raw Material Table 69. Key Suppliers of Raw Materials Table 70. Pomalidomide API Distributors List Table 71. Pomalidomide API Customer List Table 72. Global Pomalidomide API Sales Forecast by Region (2023-2028) & (Kg) Table 73. Global Pomalidomide API Sales Market Forecast by Region Table 74. Global Pomalidomide API Revenue Forecast by Region (2023-2028) & ($ millions) Table 75. Global Pomalidomide API Revenue Market Share Forecast by Region (2023-2028) Table 76. Americas Pomalidomide API Sales Forecast by Country (2023-2028) & (Kg) Table 77. Americas Pomalidomide API Revenue Forecast by Country (2023-2028) & ($ millions) Table 78. APAC Pomalidomide API Sales Forecast by Region (2023-2028) & (Kg) Table 79. APAC Pomalidomide API Revenue Forecast by Region (2023-2028) & ($ millions) Table 80. Europe Pomalidomide API Sales Forecast by Country (2023-2028) & (Kg) Table 81. Europe Pomalidomide API Revenue Forecast by Country (2023-2028) & ($ millions) Table 82. Middle East & Africa Pomalidomide API Sales Forecast by Country (2023-2028) & (Kg) Table 83. Middle East & Africa Pomalidomide API Revenue Forecast by Country (2023-2028) & ($ millions) Table 84. Global Pomalidomide API Sales Forecast by Purity (2023-2028) & (Kg) Table 85. Global Pomalidomide API Sales Market Share Forecast by Purity (2023-2028) Table 86. Global Pomalidomide API Revenue Forecast by Purity (2023-2028) & ($ Millions) Table 87. Global Pomalidomide API Revenue Market Share Forecast by Purity (2023-2028) Table 88. Global Pomalidomide API Sales Forecast by Application (2023-2028) & (Kg) Table 89. Global Pomalidomide API Sales Market Share Forecast by Application (2023-2028) Table 90. Global Pomalidomide API Revenue Forecast by Application (2023-2028) & ($ Millions) Table 91. Global Pomalidomide API Revenue Market Share Forecast by Application (2023-2028) Table 92. Mylan Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors Table 93. Mylan Pomalidomide API Product Offered Table 94. Mylan Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022) Table 95. Mylan Main Business Table 96. Mylan Latest Developments Table 97. Dr. Reddy's Laboratories Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors Table 98. Dr. Reddy's Laboratories Pomalidomide API Product Offered Table 99. Dr. Reddy's Laboratories Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022) Table 100. Dr. Reddy's Laboratories Main Business Table 101. Dr. Reddy's Laboratories Latest Developments Table 102. Hetero Drugs Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors Table 103. Hetero Drugs Pomalidomide API Product Offered Table 104. Hetero Drugs Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022) Table 105. Hetero Drugs Main Business Table 106. Hetero Drugs Latest Developments Table 107. Mac-Chem Products (India) Pvt.Ltd Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors Table 108. Mac-Chem Products (India) Pvt.Ltd Pomalidomide API Product Offered Table 109. Mac-Chem Products (India) Pvt.Ltd Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022) Table 110. Mac-Chem Products (India) Pvt.Ltd Main Business Table 111. Mac-Chem Products (India) Pvt.Ltd Latest Developments Table 112. Shilpa Medicare Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors Table 113. Shilpa Medicare Pomalidomide API Product Offered Table 114. Shilpa Medicare Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022) Table 115. Shilpa Medicare Main Business Table 116. Shilpa Medicare Latest Developments Table 117. Veranova Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors Table 118. Veranova Pomalidomide API Product Offered Table 119. Veranova Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022) Table 120. Veranova Main Business Table 121. Veranova Latest Developments Table 122. Natco Pharma Limited Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors Table 123. Natco Pharma Limited Pomalidomide API Product Offered Table 124. Natco Pharma Limited Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022) Table 125. Natco Pharma Limited Main Business Table 126. Natco Pharma Limited Latest Developments Table 127. Mehta API Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors Table 128. Mehta API Pomalidomide API Product Offered Table 129. Mehta API Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022) Table 130. Mehta API Main Business Table 131. Mehta API Latest Developments Table 132. Symed Labs Limited Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors Table 133. Symed Labs Limited Pomalidomide API Product Offered Table 134. Symed Labs Limited Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022) Table 135. Symed Labs Limited Main Business Table 136. Symed Labs Limited Latest Developments Table 137. Hangzhou Longshine Bio-Tech Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors Table 138. Hangzhou Longshine Bio-Tech Pomalidomide API Product Offered Table 139. Hangzhou Longshine Bio-Tech Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022) Table 140. Hangzhou Longshine Bio-Tech Main Business Table 141. Hangzhou Longshine Bio-Tech Latest Developments Table 142. Guangzhou Tosun Pharmaceutical Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors Table 143. Guangzhou Tosun Pharmaceutical Pomalidomide API Product Offered Table 144. Guangzhou Tosun Pharmaceutical Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022) Table 145. Guangzhou Tosun Pharmaceutical Main Business Table 146. Guangzhou Tosun Pharmaceutical Latest Developments Table 147. Sumar Biotech Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors Table 148. Sumar Biotech Pomalidomide API Product Offered Table 149. Sumar Biotech Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022) Table 150. Sumar Biotech Main Business Table 151. Sumar Biotech Latest Developments Table 152. Deva Holding AS Basic Information, Pomalidomide API Manufacturing Base, Sales Area and Its Competitors Table 153. Deva Holding AS Pomalidomide API Product Offered Table 154. Deva Holding AS Pomalidomide API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022) Table 155. Deva Holding AS Main Business Table 156. Deva Holding AS Latest Developments List of Figures Figure 1. Picture of Pomalidomide API Figure 2. Pomalidomide API Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Pomalidomide API Sales Growth Rate 2017-2028 (Kg) Figure 7. Global Pomalidomide API Revenue Growth Rate 2017-2028 ($ Millions) Figure 8. Pomalidomide API Sales by Region (2021 & 2028) & ($ millions) Figure 9. Product Picture of Above 98 % Figure 10. Product Picture of Above 99 % Figure 11. Global Pomalidomide API Sales Market Share by Purity in 2021 Figure 12. Global Pomalidomide API Revenue Market Share by Purity (2017-2022) Figure 13. Pomalidomide API Consumed in Capsules Figure 14. Global Pomalidomide API Market: Capsules (2017-2022) & (Kg) Figure 15. Pomalidomide API Consumed in Others Figure 16. Global Pomalidomide API Market: Others (2017-2022) & (Kg) Figure 17. Global Pomalidomide API Sales Market Share by Application (2017-2022) Figure 18. Global Pomalidomide API Revenue Market Share by Application in 2021 Figure 19. Pomalidomide API Revenue Market by Company in 2021 ($ Million) Figure 20. Global Pomalidomide API Revenue Market Share by Company in 2021 Figure 21. Global Pomalidomide API Sales Market Share by Geographic Region (2017-2022) Figure 22. Global Pomalidomide API Revenue Market Share by Geographic Region in 2021 Figure 23. Global Pomalidomide API Sales Market Share by Region (2017-2022) Figure 24. Global Pomalidomide API Revenue Market Share by Country/Region in 2021 Figure 25. Americas Pomalidomide API Sales 2017-2022 (Kg) Figure 26. Americas Pomalidomide API Revenue 2017-2022 ($ Millions) Figure 27. APAC Pomalidomide API Sales 2017-2022 (Kg) Figure 28. APAC Pomalidomide API Revenue 2017-2022 ($ Millions) Figure 29. Europe Pomalidomide API Sales 2017-2022 (Kg) Figure 30. Europe Pomalidomide API Revenue 2017-2022 ($ Millions) Figure 31. Middle East & Africa Pomalidomide API Sales 2017-2022 (Kg) Figure 32. Middle East & Africa Pomalidomide API Revenue 2017-2022 ($ Millions) Figure 33. Americas Pomalidomide API Sales Market Share by Country in 2021 Figure 34. Americas Pomalidomide API Revenue Market Share by Country in 2021 Figure 35. United States Pomalidomide API Revenue Growth 2017-2022 ($ Millions) Figure 36. Canada Pomalidomide API Revenue Growth 2017-2022 ($ Millions) Figure 37. Mexico Pomalidomide API Revenue Growth 2017-2022 ($ Millions) Figure 38. Brazil Pomalidomide API Revenue Growth 2017-2022 ($ Millions) Figure 39. APAC Pomalidomide API Sales Market Share by Region in 2021 Figure 40. APAC Pomalidomide API Revenue Market Share by Regions in 2021 Figure 41. China Pomalidomide API Revenue Growth 2017-2022 ($ Millions) Figure 42. Japan Pomalidomide API Revenue Growth 2017-2022 ($ Millions) Figure 43. South Korea Pomalidomide API Revenue Growth 2017-2022 ($ Millions) Figure 44. Southeast Asia Pomalidomide API Revenue Growth 2017-2022 ($ Millions) Figure 45. India Pomalidomide API Revenue Growth 2017-2022 ($ Millions) Figure 46. Australia Pomalidomide API Revenue Growth 2017-2022 ($ Millions) Figure 47. Europe Pomalidomide API Sales Market Share by Country in 2021 Figure 48. Europe Pomalidomide API Revenue Market Share by Country in 2021 Figure 49. Germany Pomalidomide API Revenue Growth 2017-2022 ($ Millions) Figure 50. France Pomalidomide API Revenue Growth 2017-2022 ($ Millions) Figure 51. UK Pomalidomide API Revenue Growth 2017-2022 ($ Millions) Figure 52. Italy Pomalidomide API Revenue Growth 2017-2022 ($ Millions) Figure 53. Russia Pomalidomide API Revenue Growth 2017-2022 ($ Millions) Figure 54. Middle East & Africa Pomalidomide API Sales Market Share by Country in 2021 Figure 55. Middle East & Africa Pomalidomide API Revenue Market Share by Country in 2021 Figure 56. Egypt Pomalidomide API Revenue Growth 2017-2022 ($ Millions) Figure 57. South Africa Pomalidomide API Revenue Growth 2017-2022 ($ Millions) Figure 58. Israel Pomalidomide API Revenue Growth 2017-2022 ($ Millions) Figure 59. Turkey Pomalidomide API Revenue Growth 2017-2022 ($ Millions) Figure 60. GCC Country Pomalidomide API Revenue Growth 2017-2022 ($ Millions) Figure 61. Manufacturing Cost Structure Analysis of Pomalidomide API in 2021 Figure 62. Manufacturing Process Analysis of Pomalidomide API Figure 63. Industry Chain Structure of Pomalidomide API Figure 64. Channels of Distribution Figure 65. Distributors Profiles